Oseltamivir

Adults: Oseltamivir Phosphate can be taken with or without food, though taking it with food may improve tolerability for some patients. For treatment of influenza in adults and adolescents 13 years and older, the recommended oral dose is 75 mg twice daily for 5 days, and treatment should begin within 2 days of the onset of influenza symptoms. The safety and efficacy of Oseltamivir for prophylaxis of influenza in pediatric patients younger than 13 years of age have not been established. For prophylaxis of influenza in adults and adolescents 13 years and older following close contact with an infected individual, the recommended oral dose is 75 mg once daily for at least 7 days, with therapy beginning within 2 days of exposure. For prophylaxis during a community outbreak of influenza, the recommended dose is 75 mg once daily; safety and efficacy have been demonstrated for up to 6 weeks, and protection lasts for as long as dosing continues.